DeepMed Research

Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Exploration of Clonal Hematopoiesis of Indeterminate Potential in Non-ischemic Heart Failure With Reduced Ejection Fraction

Completed

Conditions: Heart Failure With Reduced Ejection Fraction

First Posted Date: 2023-08-08

Last Posted Date: 2023-11-13

Lead Sponsor: Yonsei University

Target Recruit Count: 100

Registration Number: NCT05981144

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Phase 4

Recruiting

Conditions: Sodium-Glucose Transporter 2 Inhibitors
Diabetes Mellitus
Cellular Senescence

Interventions: Drug: Glimepiride
Drug: SGLT2 inhibitor

First Posted Date: 2023-08-04

Last Posted Date: 2024-05-09

Lead Sponsor: Yonsei University

Target Recruit Count: 92

Registration Number: NCT05975528

Locations: 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of

The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era

Active, not recruiting

Conditions: Dilated Cardiomyopathy
Heart Failure, Reduced Ejection Fraction
Ventricular Remodeling

First Posted Date: 2023-08-03

Last Posted Date: 2023-08-03

Lead Sponsor: Yonsei University

Target Recruit Count: 500

Registration Number: NCT05973591

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Efficacy of Fexuprazan for Prevention or Control of Gastritis Symptoms in Patients on Treatment With Systemic Steroids

Phase 4

Not yet recruiting

Conditions: Patients on Treatment With Systemic Steroids

Interventions: Drug: Fexuprazan Hydrochloride
Drug: Lansoprazole

First Posted Date: 2023-07-14

Last Posted Date: 2023-07-14

Lead Sponsor: Yonsei University

Target Recruit Count: 70

Registration Number: NCT05946135

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

Data Acquisition for Connected Network for EMSs Comprehensive Technical-support Using Artificial Intelligence

Completed

Conditions: Emergency Patients Being Transported by Rescue Ambulance

First Posted Date: 2023-07-11

Last Posted Date: 2023-07-11

Lead Sponsor: Yonsei University

Target Recruit Count: 15296

Registration Number: NCT05939258

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients

Not Applicable

Recruiting

Conditions: Coronary Artery Disease

Interventions: Drug: Clopidogrel monotherapy
Drug: Tailored anti-platelet therapy

First Posted Date: 2023-07-10

Last Posted Date: 2023-08-30

Lead Sponsor: Yonsei University

Target Recruit Count: 3434

Registration Number: NCT05936606

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of

Biomarker Screening for Immunotherapy Response Evaluation Using Microneedle Patch in Patients with Allergic Rhinitis

Recruiting

Conditions: Rhinitis, Allergic

Interventions: Other: Evaluation of clinical indicators, Sample collection before& after immunotherapy
Other: Sample collection before& after immunotherapy

First Posted Date: 2023-06-28

Last Posted Date: 2025-03-11

Lead Sponsor: Yonsei University

Target Recruit Count: 30

Registration Number: NCT05922176

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Assessment of Salbutamol Effect on Arterial Oxygenation in COPD Patients During One-lung Ventilation

Not Applicable

Recruiting

Conditions: Chronic Obstructive Pulmonary Disease
One-lung Ventilation

Interventions: Drug: 5ml of inhaled normal saline
Drug: 2.5mg (2.5ml) of inhaled salbutamol and 2.5ml of inhaled normal saline

First Posted Date: 2023-06-22

Last Posted Date: 2023-06-22

Lead Sponsor: Yonsei University

Target Recruit Count: 90

Registration Number: NCT05914285

Locations: 🇰🇷
Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma

Phase 2

Not yet recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: AtezoBev with combined radiotherapy

First Posted Date: 2023-06-18

Last Posted Date: 2023-06-18

Lead Sponsor: Yonsei University

Target Recruit Count: 51

Registration Number: NCT05908916

Locations: 🇰🇷
Severance hospital, Seoul, Korea, Republic of

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

Phase 4

Recruiting

Conditions: Coronary Artery Disease
Dyslipidemias

Interventions: Drug: a high dose of statin/ezetimib

First Posted Date: 2023-06-18

Last Posted Date: 2024-03-15

Lead Sponsor: Yonsei University

Target Recruit Count: 200

Registration Number: NCT05910476

Locations: 🇰🇷
Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy